AXIM BIOTECHNOLOGIES, INC. Convertible Notes Payable
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Convertible Notes Payable of $4.25 million as of 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2024-04-16
- 2023-12-31: Convertible Notes Payable $4.25M.
- 2023-09-30: Convertible Notes Payable $4.11M.
- 2023-06-30: Convertible Notes Payable $4.07M.
- 2023-03-31: Convertible Notes Payable $4.04M.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2023-12-31 | $4.25M 10-K · filed 2024-04-16 | |
| 2023-09-30 | $4.11M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $4.07M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $4.04M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $4.26M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $0.00 10-Q/A · filed 2022-11-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $1.13M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $1.99M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $1.98M 10-Q · filed 2021-08-23 | |
| 2020-12-31 | $0.00 10-K/A · filed 2022-04-19 | $2.52M 10-Q · filed 2021-08-23 |
| 2018-09-30 | $2.82M 10-Q · filed 2018-11-14 | |
| 2017-12-31 | $4.64M 10-Q · filed 2018-11-14 | |
| 2017-03-31 | $46.19K 10-Q · filed 2017-09-14 | |
| 2016-12-31 | $45.79K 10-Q · filed 2017-09-14 | |
| 2016-09-30 | $3.93K 10-Q · filed 2016-11-30 | |
| 2016-06-30 | $265.49K 10-Q · filed 2016-08-25 | |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-30 | $411.20K 10-Q · filed 2016-08-25 |